InDex Pharmaceuticals Holding AB Financial Overview
InDex Pharmaceuticals Holding AB's market cap is currently €271.87M. The company's EPS TTM is €-0.16364896599999998; its P/E ratio is -10.74; InDex Pharmaceuticals Holding AB is scheduled to report earnings on October 22, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
